IPO GlycoMimetics (GLYC) is a biotechnology company focused on the discovery and development of drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. GlycoMimetics is focusing initial efforts on drug candidates for rare diseases that the company believes will qualify for orphan drug designation.
Get an advisory report for this company's Initial Public Offering
View this company's prospectus
No comments:
Post a Comment